CEO, Breast Cancer Survivor Discusses New Gel to Improve Sexual Quality of Life in Patients with Cancer

Video

Breast cancer survivor and Evofem Biosciences founder and CEO Saundra Pelletier shares her thoughts on a new hormone-free contraceptive gel that could improve sexual quality of life in patients with cancer.

In 2018, Evofem Biosciences founder and CEO Saundra Pelletier was developing Phexxi, a non-hormonal contraceptive gel for women, when she was blindsided by a diagnosis of aggressive, stage 3 breast cancer. After treatments that included chemotherapy, a double mastectomy and a hysterectomy, Pelletier was soon celebrating being cancer-free, and also the Food and Drug Administration approval of her revolutionary product.

Through her firsthand experience with cancer, Pelletier learned that a non-hormonal contraceptive gel like Phexxi is not just beneficial for its contraceptive properties, but can also help women with cancer and survivors improve their sexual quality of life.

“Why Phexxi is so important and special, is that it allows these women to still have intimacy. They don't have to worry about this product interacting with them (and) the things they're doing. They don't have to worry about hormones in their body,” Pelletier said.

“Pleasurable sex should not be something that's off the table for you. You should get to care about your sexuality as much as anybody, and perhaps more so, because you should definitely get the benefit of the upside. Have a little joy after you go through all this hell, you know?”

Transcription:

I've talked to a lot of cancer patients in survivorship, and they have said that vaginal dryness is very, very serious, but it's awkward. And they feel that they're not ashamed of it, but they don't really talk about it. And they don't really know who to talk about it. A lot of these women, they say to me, “Look, I'm lucky to be alive.” I feel like it makes people think “What is wrong with me that I want to talk about sexuality? What am I, a nymphomaniac?” And you know, we sort of joke about it.

But I recently talked to an oncologist, Dr. Doshi, and she said to me, “You know, when men go through cancer treatment, particularly for prostate issues, their number one concern is, can they still get an erection?” She said, “I want you to imagine if a woman said, well, I'm very worried about (whether) I (can) still have an orgasm? They would think that a woman was crazy, and she should just carry about care about saving her life!”

So the quality of life for women, I believe, is something that we need to talk about more, and that we need to lean into. It's not just the physical impacts of cancer. And yes, we're starting to talk about the psychological impacts that happen. But we also need to talk about the sexual impacts, because a lot of these women have partners, and they still want to have intimacy, and they don't want cancer to change their life, they want to go back to the life they had before they were diagnosed.

And so, why Phexxi is so important and special, is that it allows these women to still have intimacy, they don't have to worry about this product interacting with them, the things they're doing, they don't have to worry about hormones in their body. And they hopefully will have a little more pleasurable sex because it's lubricating already. And they don't have to worry about some lubricant that they don't know what the ingredients are in either.

So, I'm really excited about that. And the final thing is that I want to be appropriately provocative, and I want to be able to say to these cancer patients, you know, look, pleasurable sex should not be something that's off the table for you. You should get to care about your sexuality as much as anybody, and perhaps more so, because you should definitely get the benefit of the upside. Have a little joy after you go through all this hell, you know?

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE